Quantitation of human herpesvirus 8 (HHV-8) antibody in patients transfused with HHV-8-seropositive blood

Transfusion

Volumn 49, Issue 10, 2009, Pages 2208-2213

  Fowlkes, Ashley L ^a   Brown, Cedric ^a   Amin, Minal M ^a   Roback, John D ^a   Downing, Robert ^a   Nzaro, Esau ^a   Mermin, Jonathan ^a   Hladik, Wolfgang ^a   Dollard, Sheila C ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BLOOD TRANSFUSION; HUMAN; HUMAN HERPESVIRUS 8; INFECTION RISK; MAJOR CLINICAL STUDY; PASSIVE IMMUNIZATION; QUANTITATIVE ANALYSIS; VIRUS INFECTION; VIRUS INFECTIVITY;

ANTIBODIES, VIRAL; BLOOD TRANSFUSION; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; UGANDA;

EID: 70350464530     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02269.x     Document Type: Article

References (21)

1. Dedicoat M, Newton R. Review of the distribution of Kaposi's sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi's sarcoma. Br J Cancer 2003 88 : 1 3.
2. Hladik W, Dollard SC, Mermin J, Fowlkes AL, Downing R, Amin MM, Banage F, Nzaro E, Kataaha P, Dondero TJ, Pellett PE, Lackritz EM. Transmission of human herpesvirus 8 by blood transfusion. N Engl J Med 2006 355 : 1331 8.
3. Alfieri C, Tanner J, Carpentier L, Perpete C, Savoie A, Paradis K, Delage G, Joncas J. Epstein-Barr virus transmission from a blood donor to an organ transplant recipient with recovery of the same virus strain from the recipient's blood and oropharynx. Blood 1996 87 : 812 7.
4. Roback JD. CMV and blood transfusions. Rev Med Virol 2002 12 : 211 9.
5. Dworkin RJ, Drew WL, Miner RC, Mehalko S, Evans C, Baxter R. Survival of cytomegalovirus in viremic blood under blood bank storage conditions. J Infect Dis 1990 161 : 1310 1.
6. Roback JD, Drew WL, Laycock ME, Todd D, Hillyer CD, Busch MP. CMV DNA is rarely detected in healthy blood donors using validated PCR assays. Transfusion 2003 43 : 314 21.
7. Drew WL, Tegtmeier G, Alter HJ, Laycock ME, Miner RC, Busch MP. Frequency and duration of plasma CMV viremia in seroconverting blood donors and recipients. Transfusion 2003 43 : 309 13.
8. Martro E, Cannon MJ, Dollard SC, Spira TJ, Laney AS, Ou CY, Pellett PE. Evidence for both lytic replication and tightly regulated human herpesvirus 8 latency in circulating mononuclear cells, with virus loads frequently below common thresholds of detection. J Virol 2004 78 : 11707 14.
9. Beneke JS, Tegtmeier GE, Alter HJ, Luetkemeyer RB, Solomon R, Bayer WL. Relation of titers of antibodies to CMV in blood donors to the transmission of cytomegalovirus infection. J Infect Dis 1984 150 : 883 8.
10. Dollard SC, Nelson KE, Ness PM, Stambolis V, Kuehnert MJ, Pellett PE, Cannon MJ. Possible transmission of human herpesvirus-8 by blood transfusion in a historical United States cohort. Transfusion 2005 45 : 500 3.
11. Pau CP, Lam LL, Spira TJ, Black JB, Stewart JA, Pellett PE, Respess RA. Mapping and serodiagnostic application of a dominant epitope within the human herpesvirus 8 ORF 65-encoded protein. J Clin Microbiol 1998 36 : 1574 7.
12. Spira TJ, Lam L, Dollard SC, Meng YX, Pau CP, Black JB, Burns D, Cooper B, Hamid M, Huong J. Comparison of serologic assays and PCR for the diagnosis of human herpesvirus 8 (HHV-8) infection. J Clin Microbiol 2000 38 : 2174 80.
13. Prins C, Gelfand EW, French LE. Intravenous immunoglobulin: properties, mode of action and practical use in dermatology. Acta Derm Venereol 2007 87 : 206 18.
14. Hollander M, Wolfe DA. Nonparametric statistical methods. Somerset (NJ) : Wiley and Sons, Inc 1999.
15. Pavenski K, Webert KE, Goldman M. Consequences of transfusion of platelet antibody: a case report and literature review. Transfusion 2008 48 : 1981 9.
16. Cannon MJ, Dollard SC, Black JB, Edlin BR, Hannah C, Hogan SE, Patel MM, Jaffe HW, Offermann MK, Spira TJ, Pellett PE, Gunthel CJ. Risk factors for Kaposi's sarcoma in men seropositive for both human herpesvirus 8 and human immunodeficiency virus. AIDS 2003 17 : 215 22.
17. Laney AS, Cannon MJ, Jaffe HW, Offermann MK, Ou CY, Radford KW, Patel MM, Spira TJ, Gunthel CJ, Pellett PE, Dollard SC. Human herpesvirus 8 presence and viral load are associated with the progression of AIDS-associated Kaposi's sarcoma. Aids 2007 21 : 1541 5.
18. Mbulaiteye SM, Biggar RJ, Bakaki PM, Pfeiffer RM, Whitby D, Owor AM, Katongole-Mbidde E, Goedert JJ, Ndugwa CM, Engels EA. Human herpesvirus 8 infection and transfusion history in children with sickle-cell disease in Uganda. J Natl Cancer Inst 2003 95 : 1330 5.
19. Orange JS, Hossny EM, Weiler CR, Ballow M, Berger M, Bonilla FA, Buckley R, Chinen J, El-Gamal Y, Mazer BD, Nelson RP Jr., Patel DD, Secord E, Sorensen RU, Wasserman RL, Cunningham-Rundles C. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol 2006 117 : S525 53.
20. Salomao R, Oliveira JS, Oliveira CF, Diaz RS, Minelli H, Valdetaro F. Passive transfer of HIV-1 antibodies and absence of HIV infection after the transfusion of HIV-1-seropositive red cells. Transfusion 2000 40 : 252 3.
21. Pellett PE, Wright DJ, Engels EA, Ablashi DV, Dollard SC, Forghani B, Glynn SA, Goedert JJ, Jenkins FJ, Lee TH, Neipel F, Todd DS, Whitby D, Nemo GJ, Busch MP. Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors. Transfusion 2003 43 : 1260 8.